1. Home
  2. GPMT vs IMA Comparison

GPMT vs IMA Comparison

Compare GPMT & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Granite Point Mortgage Trust Inc.

GPMT

Granite Point Mortgage Trust Inc.

HOLD

Current Price

$0.94

Market Cap

64.7M

Sector

Real Estate

ML Signal

HOLD

IMA

ImageneBio Inc.

HOLD

Current Price

$4.86

Market Cap

66.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPMT
IMA
Founded
2015
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
64.7M
66.3M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
GPMT
IMA
Price
$0.94
$4.86
Analyst Decision
Buy
Hold
Analyst Count
2
2
Target Price
$3.00
★ $16.00
AVG Volume (30 Days)
★ 298.8K
13.9K
Earning Date
05-05-2026
05-15-2026
Dividend Yield
★ 12.99%
N/A
EPS Growth
★ 73.58
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $800,000.00
Revenue This Year
$458.85
N/A
Revenue Next Year
$8.63
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.81
$3.94
52 Week High
$3.03
$9.10

Technical Indicators

Market Signals
Indicator
GPMT
IMA
Relative Strength Index (RSI) 26.29 36.52
Support Level N/A $4.73
Resistance Level $1.56 $6.13
Average True Range (ATR) 0.05 0.32
MACD -0.00 0.00
Stochastic Oscillator 3.49 26.67

Price Performance

Historical Comparison
GPMT
IMA

About GPMT Granite Point Mortgage Trust Inc.

Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the commercial property.

About IMA ImageneBio Inc.

ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.

Share on Social Networks: